January 5, 2018 | City of Hope
Michael A. Caligiuri, M.D., a world-renowned cancer researcher, has been named president of City of Hope National Medical Center and physician-in-chief of City of Hope.
Building Better Antibodies with John Williams, Ph.D.
April 19, 2018 | City of Hope
Researchers at Beckman Research Institute of City of Hope use novel technology to add new functionalities to already potent proteins.
New Scientist dedicates much of his research program to acute myeloid leukemia
February 27, 2018 | City of Hope
Jianjun Chen, Ph.D.'s, long-term goal is to further advance the understanding of cancer biology, and AML in particular, and to translate the discoveries from basic research into clinical application.
City of Hope Researcher Seeks New Cure for Hemophilia
February 21, 2018 | Katie Neith
Saswati Chatterjee, Ph.D., a professor in the Department of Surgery and member of the Beckman Research Institute at City of Hope, thinks she may know a way to cure hemophilia A.
City of Hope's CEACAM Research Comes Full Circle with New CAR T Approach
February 9, 2018 | Jyoti Madhusoodanan
More than 50 years after its discovery, CEA remains one of the most widely used clinical markers of cancer. As the diverse roles of CEA and its family members, known as CEA-related cell adhesion molecules (CEACAMs), have grown clearer, researchers at City of Hope are working on a new wave of clinical tools and therapies.